• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB Back to Search Results
Catalog Number 7D2648
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/31/2019
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at alere scarborough on retained kit lot 101439 with the following internal whole blood and serum plasma control samples: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lot 101439 were reviewed.This lot met the required release specifications and there were no notes indicating conflicting results within the 20-30 minutes reading timeframe.A photograph of the test device which was provided by the customer was reviewed.A single alere determine hiv 1/2 ag/ab combo test device was observed with a valid control line, and a visible ag line.No ab line was visible.The sample pad was observed to be saturated, and the sample appeared to migrate completely up the test strip.A review of the complaints reported conflicting results related to lot number 101439 showed that the complaint rate is (b)(4).The evidence available does not indicate that the product is performing outside label claims.Alere (b)(4) was unable to determine the exact root cause of the reported issue.The available evidence suggests that this device lot is performing within labeled claims.
 
Event Description
A customer reported an alere determine hiv 1/2 ag/ab combo test result was initially read as (b)(6) at 20 minutes and then appeared (b)(6) for ag (faint line) at or before 30 minutes.The patient was retested with the alere determine hiv 1/2 ag/ab combo on a different day, and the results were (b)(6) at 30 minutes.The conflicting results originally observed on the first test within the reading time-frame of 20-30 minutes, suggest a malfunction may have occurred as the results would be expected to be the same.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV 1/2 AG/AB COMBO
Type of Device
IVD FOR HIV AG/AB
Manufacturer (Section D)
ALERE SCARBOROUGH INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
benjamin crystal
10 southgate road
scarborough, ME 04074
2077305820
MDR Report Key8349653
MDR Text Key139183495
Report Number1221359-2019-00009
Device Sequence Number1
Product Code MZF
UDI-Device Identifier10811877010293
UDI-Public011081187701029310101439
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/23/2020
Device Catalogue Number7D2648
Device Lot Number101439
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2019
Initial Date FDA Received02/19/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-